Feb 27 (Reuters) - Cyclacel Pharmaceuticals Inc CYCC.O:
CYCLACEL PHARMACEUTICALS ANNOUNCES CLOSING OF A CHANGE OF CONTROL TRANSACTION AND APPOINTMENT OF NEW EXECUTIVE LEADERSHIP
CYCLACEL PHARMACEUTICALS INC - DAVID LAZAR RESIGNS AS INTERIM CEO AND SECRETARY
CYCLACEL PHARMACEUTICALS INC - DATUK DR. DORIS WONG SING EE ELECTED AS CEO AND EXECUTIVE DIRECTOR
CYCLACEL PHARMACEUTICALS INC - KIU CU SENG APPOINTED AS EXECUTIVE DIRECTOR, SECRETARY AND CFO
Source text: ID:nGNX2q1q8
Further company coverage: CYCC.O
((Reuters.Briefs@thomsonreuters.com;))
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。